Pesquisas alternativas:
care company » core company (Expandir a Pesquisa), large company (Expandir a Pesquisa), share company (Expandir a Pesquisa)
nab compared » swab compared (Expandir a Pesquisa), b compared (Expandir a Pesquisa), tb compared (Expandir a Pesquisa)
company law » company a (Expandir a Pesquisa)
compared a » compared _ (Expandir a Pesquisa), compare a (Expandir a Pesquisa), compare _ (Expandir a Pesquisa)
can newts » can new (Expandir a Pesquisa), can newly (Expandir a Pesquisa)
law new » jaw new (Expandir a Pesquisa)
j nagy » a nagy (Expandir a Pesquisa), _ nagy (Expandir a Pesquisa), d nagy (Expandir a Pesquisa)
j care » j carel (Expandir a Pesquisa), j carey (Expandir a Pesquisa), j carne (Expandir a Pesquisa)
_ nab » _ nad (Expandir a Pesquisa)
a net » a new (Expandir a Pesquisa), _ net (Expandir a Pesquisa), u net (Expandir a Pesquisa)
care company » core company (Expandir a Pesquisa), large company (Expandir a Pesquisa), share company (Expandir a Pesquisa)
nab compared » swab compared (Expandir a Pesquisa), b compared (Expandir a Pesquisa), tb compared (Expandir a Pesquisa)
company law » company a (Expandir a Pesquisa)
compared a » compared _ (Expandir a Pesquisa), compare a (Expandir a Pesquisa), compare _ (Expandir a Pesquisa)
can newts » can new (Expandir a Pesquisa), can newly (Expandir a Pesquisa)
law new » jaw new (Expandir a Pesquisa)
j nagy » a nagy (Expandir a Pesquisa), _ nagy (Expandir a Pesquisa), d nagy (Expandir a Pesquisa)
j care » j carel (Expandir a Pesquisa), j carey (Expandir a Pesquisa), j carne (Expandir a Pesquisa)
_ nab » _ nad (Expandir a Pesquisa)
a net » a new (Expandir a Pesquisa), _ net (Expandir a Pesquisa), u net (Expandir a Pesquisa)
1
Por Gray, Richard T., Watson, Jo, Cogle, Aaron J., Smith, Don E., Hoy, Jennifer F., Bastian, Lisa A., Finlayson, Robert, Drummond, Fraser M., Whittaker, Bill, Law, Matthew G., Petoumenos, Kathy
Publicado no Sex Health (2018)
“.... The model estimated the total median discounted (5%) cost for ART and associated care to be A$36 million...”Publicado no Sex Health (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Awasthi, Niranjan, Zhang, Changhua, Schwarz, Anna M., Hinz, Stefan, Wang, Changguang, Williams, Noelle S., Schwarz, Margaret A., Schwarz, Roderich E.
Publicado em 2013
“... of docetaxel or nab-paclitaxel decreased gemcitabine IC(50). Net tumor growth inhibition after gemcitabine...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Awasthi, Niranjan, Zhang, Changhua, Schwarz, Anna M., Hinz, Stefan, Schwarz, Margaret A., Schwarz, Roderich E.
Publicado no Mol Cancer Ther (2014)
“...Nanoparticle albumin–bound paclitaxel (nab-paclitaxel, NPT) has recently shown efficacy...”Publicado no Mol Cancer Ther (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por ZHANG, CHANG-HUA, AWASTHI, NIRANJAN, SCHWARZ, MARGARET A., SCHWARZ, RODERICH E.
Publicado em 2013
“...235 and nab-paclitaxel caused an increase in PARP-1 and caspase-3 cleavage. Net local tumor growth...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Awasthi, Niranjan, Scire, Emily, Monahan, Sheena, Grojean, Meghan, Zhang, Eric, Schwarz, Margaret A., Schwarz, Roderich E.
Publicado no Oncotarget (2016)
“... survival was increased compared to controls (21 days) after therapy with nab-paclitaxel (40 days, a 90...”Publicado no Oncotarget (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Radonovich, Lewis J., Wizner, Kerri, LaVela, Sherri L., Lee, Martin L., Findley, Kimberly, Yorio, Patrick
Publicado no PLoS One (2019)
“... with two respirator manufacturers, Company A and B, to bring new RPD with improved tolerability to the U.S...”Publicado no PLoS One (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Azzariti A, Brunetti O, Porcelli L, Graziano G, Iacobazzi RM, Signorile M, Scarpa A, Lorusso V, Silvestris N
Publicado em 2016-07-01
Assuntos:
“...gemcitabine/nab-paclitaxel...”Publicado em 2016-07-01
Obter o texto integral
Artigo
8
Por A. M. Lila, V. I. Mazurov, E. V. Zonova, O. B. Nesmeyanova, T. V. Plaksina, D. G. Krechikova, O. V. Reshet’ko, L. N. Denisov, I. G. Gordeev, T. G. Pokrovskaya, O. V. Antipova, T. V. Kropotina, T. V. Povarova, P. A. Shesternya, E. N. Ushakova, N. F. Soroka, E. V. Kunder, A. V. Eremeeva, E. V. Chernyaeva, R. A. Ivanov, P. S. Pukhtinskaya
Publicado em 2018-07-01
“... different in the rate of and reasons for patient withdrawal from the study. A comparable number of patients...”Publicado em 2018-07-01
Obter o texto integral
Artigo
9
Por Mammì, Maria, Citraro, Rita, Torcasio, Giovanni, Cusato, Gennaro, Palleria, Caterina, di Paola, Eugenio Donato
Publicado em 2013
“... measures in order to improve the operation of Union law on the pharmacovigilance of medicinal products...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
“... direct-to-consumer (DTC) companies and several offer tests not considered standard of care. To address...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Frybourg, Sandrine, Remuzat, Cécile, Kornfeld, Åsa, Toumi, Mondher
Publicado no J Mark Access Health Policy (2015)
“... professionals and companies and covers a vast range of health products. Commercial sales agreements of goods...”Publicado no J Mark Access Health Policy (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Sara Gottesman
Publicado em 2022-05-01
Assuntos:
“...Direct Primary Care...”Publicado em 2022-05-01
Obter o texto integral
Artigo
13
Por Doran, Rachel C., Yu, Bin, Wright, Meredith, O'Rourke, Sara M., Yin, Lu, Richardson, Jennie M., Byrne, Gabriel, Mesa, Kathryn A., Berman, Phillip W.
Publicado no Front Immunol (2018)
“... displays a lower degree of net charge and glycoform heterogeneity as compared to rgp120s produced in normal...”Publicado no Front Immunol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
“... infertility care, then examine the state insurance laws relevant to male infertility, and close with a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Publicado no New Frontiers in Regional Science: Asian Perspectives
(2021)
Assuntos:
“...Company, commercial & competition law: general...”Obter o texto integral
Livro
16
Por Phillips, Anthony George, Hongaard-Andersen, Peter, Moscicki, Richard A., Sahakian, Barbara, Quirion, Rémi, Krishnan, K. Ranga Rama, Race, Tim
Publicado no Int J Neuropsychopharmacol (2015)
“... a summit to discuss ways to reverse this disturbing trend through new partnerships to accelerate CNS...”Publicado no Int J Neuropsychopharmacol (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Skipka, Guido, Wieseler, Beate, Kaiser, Thomas, Thomas, Stefanie, Bender, Ralf, Windeler, Jürgen, Lange, Stefan
Publicado no Biom J (2016)
“... of assessment, which examines whether a new drug shows an added benefit (a positive patient‐relevant treatment...”Publicado no Biom J (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Celeste, Edoardo, Palladino, Nicola, Redeker, Dennis, Yilma, Kinfe
Publicado no Information Technology and Global Governance (2023)
Assuntos:
“...thema EDItEUR::J Society and Social Sciences::JP Politics and government::JPP Public administration...”Publicado no Information Technology and Global Governance (2023)
Obter o texto integral
Livro
19
“... cytoskeleton compared with NET1A, the founding member of the NET family. The C-terminal domain of NET3B links...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Rashkin, Sara R., Chua, Katherina C., Ho, Carol, Mulkey, Flora, Jiang, Chen, Mushiroda, Tasei, Kubo, Michiaki, Friedman, Paula N., Rugo, Hope S., McLeod, Howard L., Ratain, Mark J., Castillos, Francisco, Naughton, Michael, Overmoyer, Beth, Toppmeyer, Deborah, Witte, John S., Owzar, Kouros, Kroetz, Deanna L.
Publicado no Clin Pharmacol Ther (2018)
“... outcomes. An elastic net was applied to a pharmacogenetic study of progression-free survival of 468...”Publicado no Clin Pharmacol Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo